Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,045
Boards Moderated 1
Alias Born 02/13/10
160x600 placeholder
Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference "Business Wire" - 11/25/2014 7:30:00 AM
European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek® "Business Wire" - 11/20/2014 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2014 4:36:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2014 4:05:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2014 2:04:49 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:39:03 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:36:26 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:20:39 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:18:19 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:09:37 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:05:45 AM
Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum Partners Reaffirms Commitment ... "Business Wire" - 11/11/2014 7:30:00 AM
Navidea Announces Third Quarter 2014 Financial Results "Business Wire" - 11/6/2014 7:30:00 AM
Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European Association of Nuclear Medici... "Business Wire" - 10/30/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Third Quarter 2014 Financial Results on November 6, 2014 "Business Wire" - 10/29/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2014 5:25:31 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 4:45:59 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 10/15/2014 4:03:40 PM
Navidea Announces Rick Gonzalez as New Chief Executive Officer "Business Wire" - 10/15/2014 8:00:00 AM
FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors "Business Wire" - 10/15/2014 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/8/2014 4:05:27 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/1/2014 1:05:05 PM
Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor Conference September 30th "Business Wire" - 9/29/2014 3:36:00 PM
Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast & Ce... "Business Wire" - 9/26/2014 7:27:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 4:40:16 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist